Head to head
BanColombia vs HDFC Bank
Side-by-side on the measures that matter, with a plain-English read. Full detail: CIB · HDB
CIB
BanColombia
81.55-1.98%
1-year price shape — +41% over the period
Quant Rating C · 82/100
vs
HDB
HDFC Bank
27.42+4.50%
1-year price shape — -24% over the period
Quant Rating D · 18/100
1-year performance, rebased to 100
BanColombia edges it on the scoreable measures. BanColombia has the highest Quant Rating (82); BanColombia has done best over the past year (+41%); BanColombia trades cheapest on trailing earnings.
| CIB | HDB | |
|---|---|---|
| Snapshot | ||
| Sector | Banks - Regional | Banks - Regional |
| Last price | 81.55 | 27.42 |
| Change today | -1.98% | +4.50% |
| 1-year return | +41.4% | -24.4% |
| Market cap | $19.26B | $140.70B |
| 52-week range | 55.87 – 104.07 | 21.36 – 36.37 |
| Valuation | ||
| P/E (TTM) | 14.71 | 18.65 |
| P/E percentile, own 5-yr range | 85th | 14th |
| P/B | 1.70 | 1.61 |
| Dividend yield | 5.33% | 1.29% |
| Profitability & growth | ||
| EPS (TTM) | 4.73 | 1.47 |
| Net profit (TTM) | $1.12B | $7.54B |
| Revenue (TTM) | $30.27T | -- |
| Provider revenue period date | 2026-09-29 | 2025-03-30 |
| Revenue growth (YoY) | +9.6% | -- |
| Gross margin | -- | -- |
| Operating margin | -- | -- |
| Net margin | 8.7% | 28.2% |
| Free cash flow (TTM) | $2.56T | -- |
| Provider cash-flow period date | 2026-06-29 | -- |
| Ownership & sentiment | ||
| Institutional ownership | 72.0% | 82.8% |
| Insider activity (12mo) | 43 buy / 7 sell | 9 buy / 4 sell |
| Short interest (% of float) | 0.3% | 0.8% |
| Analyst consensus | 50% buy / 50% hold (2) | 100% buy (1) |
| Analyst price target | $105 (+29%) | -- |
| StockVane view | ||
| StockVane Quant Rating | C (82) | D (18) |
| Company | ||
| Employees | 33,951 | 211,535 |
| Founded | -- | 1994 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.